Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for iRadimed Corporation (IRMD : NSDQ)
 
 • Company Description   
iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump modules; dose error reduction systems; Masimo SET SpO2 monitoring products; and MRI Pulse oximeters, and MRI oximeter remotes and displays under the iMagox name used during MRI procedures. iRadimed Corporation is headquartered in Winter Park, Florida.

Number of Employees: 160

 
 • Price / Volume Information   
Yesterday's Closing Price: $61.80 Daily Weekly Monthly
20 Day Moving Average: 60,631 shares
Shares Outstanding: 12.72 (millions)
Market Capitalization: $785.79 (millions)
Beta: 0.91
52 Week High: $63.29
52 Week Low: $42.34
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 2.15% -2.39%
12 Week 18.19% 0.95%
Year To Date 12.36% 5.25%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1025 Willa Springs Dr.
-
Winter Springs,FL 32708
USA
ph: 407-677-8022
fax: 407-677-5037
investorrelations@iradimed.com http://www.iradimed.com
 
 • General Corporate Information   
Officers
Roger Susi - Chairman; Chief Executive Officer and President
John Glenn - Chief Financial Officer and Secretary
Monty Allen - Director
Anthony Vuoto - Director
James Hawkins - Director

Peer Information
iRadimed Corporation (ABMD)
iRadimed Corporation (DMDS)
iRadimed Corporation (CPWY.)
iRadimed Corporation (EQUR)
iRadimed Corporation (ECIA)
iRadimed Corporation (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 46266A109
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/07/25
Share - Related Items
Shares Outstanding: 12.72
Most Recent Split Date: (:1)
Beta: 0.91
Market Capitalization: $785.79 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 1.10%
Current Fiscal Quarter EPS Consensus Estimate: $0.41 Indicated Annual Dividend: $0.68
Current Fiscal Year EPS Consensus Estimate: $1.63 Payout Ratio: 0.44
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.31
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 05/20/2025 - $0.17
Next EPS Report Date: 08/07/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 37.91
Trailing 12 Months: 39.87
PEG Ratio: -
Price Ratios
Price/Book: 8.73
Price/Cash Flow: 39.06
Price / Sales: 10.46
EPS Growth
vs. Year Ago Period: 15.63%
vs. Previous Quarter: -7.50%
Sales Growth
vs. Year Ago Period: 10.87%
vs. Previous Quarter: 0.63%
ROE
06/30/25 - -
03/31/25 - 23.28
12/31/24 - 23.60
ROA
06/30/25 - -
03/31/25 - 20.59
12/31/24 - 20.76
Current Ratio
06/30/25 - -
03/31/25 - 8.87
12/31/24 - 8.84
Quick Ratio
06/30/25 - -
03/31/25 - 7.62
12/31/24 - 7.62
Operating Margin
06/30/25 - -
03/31/25 - 26.32
12/31/24 - 26.26
Net Margin
06/30/25 - -
03/31/25 - 26.33
12/31/24 - 26.26
Pre-Tax Margin
06/30/25 - -
03/31/25 - 33.23
12/31/24 - 33.14
Book Value
06/30/25 - -
03/31/25 - 7.08
12/31/24 - 6.85
Inventory Turnover
06/30/25 - -
03/31/25 - 1.57
12/31/24 - 1.46
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©